The cumulative results of predictors and structural protein indicate that selected tumor-associated PTPRS mutation is a strong candidate to be associated with the development of non-RET MTC, but mutational screening of this gene in these familial cases should be clarified. The gene discussed is RET; the disease is medullary thyroid gland carcinoma.